JP2008503447A5 - - Google Patents

Download PDF

Info

Publication number
JP2008503447A5
JP2008503447A5 JP2007513845A JP2007513845A JP2008503447A5 JP 2008503447 A5 JP2008503447 A5 JP 2008503447A5 JP 2007513845 A JP2007513845 A JP 2007513845A JP 2007513845 A JP2007513845 A JP 2007513845A JP 2008503447 A5 JP2008503447 A5 JP 2008503447A5
Authority
JP
Japan
Prior art keywords
phenyl
disease
thiazol
acetic acid
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007513845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503447A (ja
Filing date
Publication date
Priority claimed from GB0412198A external-priority patent/GB0412198D0/en
Priority claimed from GB0414194A external-priority patent/GB0414194D0/en
Priority claimed from GB0424016A external-priority patent/GB0424016D0/en
Application filed filed Critical
Priority claimed from PCT/EP2005/005882 external-priority patent/WO2005116001A1/en
Publication of JP2008503447A publication Critical patent/JP2008503447A/ja
Publication of JP2008503447A5 publication Critical patent/JP2008503447A5/ja
Withdrawn legal-status Critical Current

Links

JP2007513845A 2004-05-29 2005-05-30 Crth2リガンドとしての置換チアゾール酢酸 Withdrawn JP2008503447A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0412198A GB0412198D0 (en) 2004-05-29 2004-05-29 Medicinal use of receptor ligands
GB0414194A GB0414194D0 (en) 2004-06-24 2004-06-24 Medicinal use of receptor ligands
GB0424016A GB0424016D0 (en) 2004-10-29 2004-10-29 Medicinal use of receptor ligands
PCT/EP2005/005882 WO2005116001A1 (en) 2004-05-29 2005-05-30 Substituted thiazoleacetic as crth2 ligands

Publications (2)

Publication Number Publication Date
JP2008503447A JP2008503447A (ja) 2008-02-07
JP2008503447A5 true JP2008503447A5 (https=) 2008-07-24

Family

ID=34968996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007513845A Withdrawn JP2008503447A (ja) 2004-05-29 2005-05-30 Crth2リガンドとしての置換チアゾール酢酸

Country Status (13)

Country Link
US (1) US20080119456A1 (https=)
EP (1) EP1758874A1 (https=)
JP (1) JP2008503447A (https=)
KR (1) KR20070044404A (https=)
AU (1) AU2005247610A1 (https=)
BR (1) BRPI0511671A (https=)
CA (1) CA2568742A1 (https=)
CR (1) CR8837A (https=)
EA (1) EA200602288A1 (https=)
IL (1) IL179693A0 (https=)
MX (1) MXPA06013924A (https=)
NO (1) NO20066049L (https=)
WO (1) WO2005116001A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0427381D0 (en) * 2004-12-14 2005-01-19 Novartis Ag Organic compounds
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
US8268872B2 (en) 2008-02-22 2012-09-18 Radius Health, Inc. Selective androgen receptor modulators
ES2488990T3 (es) 2008-02-22 2014-09-01 Radius Health, Inc. Moduladores selectivos del receptor de andrógenos
JP5535931B2 (ja) 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
US20110288142A1 (en) * 2009-01-30 2011-11-24 Chen Pingyun Y CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
SG181900A1 (en) 2009-12-23 2012-08-30 Ironwood Pharmaceuticals Inc Crth2 modulators
MX338831B (es) 2010-02-04 2016-05-03 Radius Health Inc Moduladores selectivos de receptores de androgenos.
EP2568806B1 (en) 2010-05-12 2016-05-11 Radius Health, Inc. Therapeutic regimens
US8642632B2 (en) 2010-07-02 2014-02-04 Radius Health, Inc. Selective androgen receptor modulators
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2790696A1 (en) 2011-12-16 2014-10-22 Atopix Therapeutics Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
LT3474841T (lt) 2016-06-22 2022-06-10 Ellipses Pharma Ltd Ar+ krūties vėžio gydymo būdai

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20000003A2 (en) * 1997-07-10 2000-12-31 Janssen Pharmaceutica Nv Il-5 inhibiting 6-azauracil derivatives
EP1045846B1 (en) * 1997-11-28 2003-05-02 Lg Chemical Limited Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
EP0987265A1 (en) * 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
CZ2002356A3 (cs) * 1999-08-06 2002-06-12 Janssen Pharmaceutica N. V. Deriváty 6-azauracilu inhibující interleukin-5
WO2003006015A1 (en) * 2001-07-13 2003-01-23 Bristol-Myers Squibb Pharma Company Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2008500991A5 (https=)
JP2008503447A5 (https=)
NZ597381A (en) Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
ES2549087T3 (es) Derivados de aminodihidrotiazina como inhibidores de BACE para el tratamiento de la enfermedad de Alzheimer
JP2021504443A5 (https=)
JP2017526711A5 (https=)
JP2009517417A5 (https=)
RU2315041C2 (ru) Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения
HRP20161177T1 (hr) Modulator glukagonskog receptora
JP2008500991A (ja) 医学的使用のためのcrth2レセプターリガンド
JP2018519323A5 (https=)
CA2587800A1 (en) Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
JP2017502940A5 (https=)
JP2007519695A5 (https=)
JP2011513305A5 (https=)
JP2015502387A5 (https=)
JP2010513434A5 (https=)
JP2010506825A5 (https=)
JP2010501003A5 (https=)
NZ566788A (en) Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation
JP2012255002A5 (https=)
JP2013541596A5 (https=)
RU2010107169A (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
JP2016529264A5 (https=)
JP2010502576A5 (https=)